Author:
Sinreih Maša,Gjorgoska Marija,Möller Gabriele,Adamski Jerzy,Rižner Tea Lanišnik
Funder
Javna Agencija za Raziskovalno Dejavnost RS
Reference42 articles.
1. Development of potential preclinical candidates with promising in vitro ADME profile for the inhibition of type 1 and type 2 17β-Hydroxysteroid dehydrogenases: Design, synthesis, and biological evaluation;Abdelsamie;European Journal of Medicinal Chemistry,2019
2. Design, synthesis, and biological characterization of orally active 17β-hydroxysteroid dehydrogenase type 2 inhibitors targeting the prevention of osteoporosis;Abdelsamie;Journal of Medicinal Chemistry,2019
3. Differential but concerted expression of HSD17B2, HSD17B3, SHBG and SRD5A1 testosterone tetrad modulate therapy response and susceptibility to disease relapse in patients with prostate cancer;Bamodu;Cancers,2021
4. Identification of the binding site on cytochrome P450 2B4 for cytochrome b5 and cytochrome P450 reductase;Bridges;Journal of Biological Chemistry,1998
5. Flavonoids and cinnamic acid derivatives as inhibitors of 17beta-hydroxysteroid dehydrogenase type 1;Brozic;Molecular and Cellular Endocrinology,2009
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献